SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending following a report that the company is preparing a potential takeover bid for eBay, fueling intense community speculation about the firm's strategic direction and financing. Discussions among retail investors are sharply divided between excitement over a potential monumental transformation and skepticism regarding the viability of such a large-scale acquisition.

eBay, Inc. is a commerce company, whose platforms include an online marketplace and its localized counterparts, including off-platform businesses in South Korea, Japan, and Turkey, as well as eBay’s suite of mobile apps. It offers a platform for various product categories, including parts and accessories, collectibles, fashion, electronics, and home & garden. eBay generates revenue mainly through fees from sales, payment processing, and advertising. The company was founded by Pierre Morad Omidyar in September 1995 and is headquartered in San Jose, CA.

EBay Inc.

eBay Inc

eBay is trending following a Wall Street Journal report that GameStop is building a stake in the company ahead of a potential takeover bid. Community discussion is heavily focused on the financial feasibility of such an acquisition given the significant market cap disparity between the two companies, with some investors dismissing the rumors as pure speculation while others express excitement over the potential for a massive retail transformation.

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

The community is actively debating the legitimacy of the MULN crypto token, with many users drawing parallels between its price action and the volatile history of its associated EV stock. Conversations are heavily polarized, featuring aggressive recruitment attempts from supporters hoping for a speculative pump alongside vocal detractors labeling the project a recurring scam.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is currently trending as investors debate whether the stock is significantly oversold following a sustained period of price consolidation and bearish sentiment. The community is focused on the upcoming earnings report as a potential catalyst, with active discussions weighing the impact of Pepsi's distribution partnership and the Alani Nu acquisition against broader concerns about channel inventory and margin compression.

WorldFinancial

World Liberty Financial is facing intense scrutiny and community backlash following a proposed governance vote to implement a multi-year token lockup, fueling ongoing debates about transparency and management's handling of the project. Investors remain sharply divided, with some betting on a recovery through upcoming supply shocks and token burns, while others label the project a scam amid concerns over insider selling and legal challenges from prominent industry figures.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is drawing significant community debate as investors weigh strong commercial launch signals for Tonmya against deep-seated frustration regarding recurring share dilution and requests for reverse split authorizations. While some bulls are encouraged by rising prescription trends and potential pipeline growth, others remain highly skeptical due to the company's historical capital management and the persistent impact on long-term shareholder value.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is trending as investors rally behind its strategic partnership with Nvidia and Meta to power data centers with small modular reactors, fueling optimism about its long-term AI-driven growth trajectory. Community discussions are highly polarized, balancing excitement over these major technology alliances and DOE milestones against skepticism regarding the company's pre-revenue status and the volatility of its high-beta shares.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Johnson & Johnson is seeing active investor interest driven by a mix of steady defensive appeal and anticipation surrounding upcoming earnings. The community is focused on the company's long-term growth prospects in oncology and medical technology, alongside ongoing discussions about the impact of legal developments on corporate strategy.

Eastman Kodak Co. engages in the provision of analog and digital innovations. It operates through the following segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment consists of Prepress Solutions, which includes Kodak's digital offset plate offerings and computer-to-plate imaging solutions. The Digital Printing segment contains Electrophotographic Printing Solutions, Prosper, Versamark and Software. The Advanced Materials and Chemicals segment consists of four lines of business: Industrial Film and Chemicals, Motion Picture, Advanced Materials and Functional Printing, and Kodak Services for Business (KSB). The Brand segment includes licensing of the Kodak brand to third parties. The company was founded by George Eastman in 1880 and is headquartered in Rochester, NY.

Eastman Kodak Co.

Eastman Kodak is surging as investors pivot toward its emerging pharmaceutical and advanced materials manufacturing capabilities, which are being positioned as a strategic domestic solution amid tightening import tariffs. The stock is seeing heavy retail and institutional interest as the community speculates on impending contract awards and potential shifts in the company's long-term growth trajectory.

IDEX

IDEX is generating significant buzz as community members discuss a potential short squeeze and a bullish breakout, fueled by optimism surrounding the protocol's upcoming liquidity initiatives and platform growth. Investors are actively debating whether the token is poised for an exponential run to higher resistance levels or if current volatility reflects a recurring pump-and-dump cycle.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pharming Group (PHAR) Expected to Announce Quarterly Earnings on Thursday

Pharming Group (NASDAQ:PHAR) will be releasing its Q1 2026 earnings before the market opens on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-pharming-group-stock...

Pharming Group (PHGUF) to Release Quarterly Earnings on Thursday

Pharming Group (OTCMKTS:PHGUF) will be releasing earnings before the market opens on Thursday, May 7. (View Earnings Report at...

Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Sees Significant Decline in Short Interest

Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR - Get Free Report) was the target of a large decline in short interest in the month of April. As of April 15th, there was short interest totaling 9,179...

Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Sees Large Decline in Short Interest

Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR - Get Free Report) was the recipient of a significant drop in short interest in March. As of March 31st, there was short interest totaling 12,882...

Pharming Group (NASDAQ:PHAR) Sees Large Volume Increase  - Here's What Happened

Pharming Group (NASDAQ:PHAR) Sees Strong Trading Volume - What's Next...

Pharming Group (OTCMKTS:PHGUF) Shares Gap Up   - Should You Buy?

Pharming Group (OTCMKTS:PHGUF) Shares Gap Up - Still a Buy...

Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Receives Average Recommendation of "Hold" from Brokerages

Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR - Get Free Report) has been given an average recommendation of "Hold" by the five analysts that are presently covering the firm, Marketbeat.com reports...

Pharming Group (NASDAQ:PHAR) Coverage Initiated at Canaccord Genuity Group

Canaccord Genuity Group began coverage on Pharming Group in a research report on Friday. They set a "buy" rating and a $37.00 price target for the company...

Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Short Interest Up 33.9% in March

Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR - Get Free Report) was the target of a significant increase in short interest in the month of March. As of March 13th, there was short interest totaling...

HC Wainwright Reaffirms "Buy" Rating for Pharming Group (NASDAQ:PHAR)

HC Wainwright reaffirmed a "buy" rating and issued a $37.00 price target on shares of Pharming Group in a research note on Tuesday...

Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following segments: RUCONEST®, Joenja®, Europe, and Rest of the World. The company was founded on November 11, 1988, and is headquartered in Leiden, the Netherlands.

Current Price	$16.98
Prev Close	$16.53
Open	$16.85
Dividend Yield	0.00%
50-Day Moving Average	$16.40
Beta	0.50
Avg. Volume	10,993.03
PE Ratio	472.98

52-Week High	$21.34
52-Week Low	$8.60
Market Capitalization	$1.2B
EPS (Annual)	$0.0415
Price to Book	4.30
Revenue Per Employee	N/A

PHAR
Pharming Group

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PHAR News

PHARPharming Group